Remoxipride

Known as: (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide, Remoxipridum, Remoxipride [Chemical/Ingredient] 
An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Intranasal (IN) administration could be an attractive mode of delivery for drugs targeting the central nervous system… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Dopamine and glutamate are key neurotransmitters involved in learning and memory mechanisms of the brain. These two… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
1999
1999
The behavioral hyperactivity elicited by most drugs of abuse has been linked to changes in mesolimbic dopamine neurotransmission… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The affinities of olanzapine, clozapine, haloperidol, and four potential antipsychotics were compared on binding to the neuronal… (More)
Is this relevant?
1995
1995
An integrated pharmacokinetic-pharmacodynamic model is suggested for remoxipride and its effect on prolactin (PRL) release acting… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The potencies of the major neuroleptics used in the treatment of schizophrenia, including haloperidol and remoxipride, correlate… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Clozapine and haloperidol produce different induction patterns of c-fos expression in the forebrain, with haloperidol increasing… (More)
Is this relevant?
1993
1993
The pharmacokinetics and metabolism of the new antipsychotic agent remoxipride ((S)-(-)-3-bromo-N(-)[(1-ethyl-2-pyrrolidinyl… (More)
Is this relevant?
Review
1990
Review
1990
In vitro receptor ligand binding studies in the rat showed that remoxipride displaced different radioligands at the dopamine D2… (More)
Is this relevant?
1989
1989
The tolerability and pharmacokinetics of remoxipride were studied in 18 healthy normal male volunteers. Increasing oral doses of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?